Bureau of Narcotic Enforcement
The Bureau of Narcotic Enforcement (BNE) protects the public health by combatting the illegal use of and trade in controlled substances and by safeguarding the legitimate use of controlled substances in healthcare as defined in law and regulations.
The Bureau of Narcotic Enforcement:
- works with local and federal law enforcement to investigate unauthorized use of prescription controlled substance medications;
- supervises and regulates controlled substances through its issuance of licenses to manufacturers, distributors, hospitals, residential health care facilities, teaching institutions, EMS agencies, and researchers;
- maintains the Prescription Monitoring Program (PMP);
- provides secure Official New York State Prescriptions to prescribers; and
- oversees the electronic prescribing of controlled substances, mandatory opioid prescriber education, and the safe disposal of medications through the statewide Drug Take Back Program.
NYS Prescription Monitoring Program (PMP) Data Submission Instructional Videos
Instructional videos for New York State Prescription Monitoring Program (PMP) Data Collection Tool are available. These videos give on-line guidance in the use of various features and functions of the PMP Data Collection Tool and data submission process. The trainings may also be accessed from within the PMP Data Collection Tool Data Collection Help area.
- NYS Prescription Monitoring Program (PMP) Reporting Requirements: This tutorial explains the requirements and steps necessary for pharmacies and practitioners to report dispensed controlled substance prescription data to the PMP.
- NYS Prescription Monitoring Program (PMP) Getting Access to the NYS Health Commerce System Training for Practitioners: This training explains the necessary steps for practitioners to gain access to the Health Commerce System in order to submit dispensing data to the PMP.
- NYS Prescription Monitoring Program (PMP) Getting Access to the NYS Health Commerce System Training for Pharmacies: This training explains the necessary steps for pharmacies to gain access to the Health Commerce System in order to submit dispensing data to the PMP.
- NYS Prescription Monitoring Program (PMP) Data Submission: This tutorial reviews the process of submitting data to the NYS PMP Registry using the PMP Data Collection Tool.
- NYS Prescription Monitoring Program (PMP) Submission Status Review: This training discusses the review of controlled substance prescription data submissions using the PMP Data Collection Tool on the Health Commerce System.
- NYS Prescription Monitoring Program (PMP) Reviewing Submitted Records: This tutorial discusses the use and layout of the Rx Review Tab within the PMP Data Collection Tool.
- NYS Prescription Monitoring Program (PMP) Error Correction: This training explains how to retrieve and correct dispensed controlled substance data that was transmitted electronically to the New York State Department of Health (NYSDOH) by pharmacists and dispensing practitioners.
Prescribing Controlled Substances in the Absence of an In-Person Medical Evaluation
Updated May 2025
Effective May 21, 2025, pursuant to 10 NYCRR § 80.63(d)(1), no controlled substance shall be prescribed prior to an in-person medical evaluation of the patient, except in certain circumstances. Among the exceptions listed in § 80.63(e), a controlled substance may be prescribed by telemedicine/telehealth, as such terms are defined by Article 29-G of New York State Public Health Law, in the absence of an in-person medical evaluation when consistent with state laws and regulations and the laws, rules, and regulations of the Drug Enforcement Administration.
In addition to this requirement, practitioners must comply with all other applicable Federal and State laws, including New York State regulations for consulting the Prescription Monitoring Program (PMP) Registry when writing prescriptions for Schedule II, III, and IV controlled substances, and the use of electronic prescribing.
Mainstreaming Addiction Treatment Act
The Mainstreaming Addiction Treatment (MAT) Act was signed into federal law and became effective on December 29, 2022. Important changes resulting from the MAT Act include the:
- Elimination of the requirement for a special registration through the federal Drug Enforcement Administration (commonly referred to as an X-waiver) to prescribe or dispense buprenorphine for the treatment of opioid use disorder (OUD).
- Elimination of the limitations on the number of patients a practitioner was permitted to treat with buprenorphine for OUD.
A practitioner holding a standard DEA registration may now prescribe buprenorphine for the treatment of OUD, without limitation to the number of patients. Nothing in 10 NYCRR §80.84 should be interpreted to contradict these changes.
Note: The federal Consolidated Appropriations Act of 2023 enacted a new one-time requirement for all DEA-registered practitioners, except veterinarians, to complete 8-hours of training in the identification and treatment of substance use disorders when renewing or completing an initial registration.
- This training is in addition to the New York State Mandatory Prescriber Education that must be completed every 3 years.
NYS Prescription Monitoring Program (PMP) Instructional Videos
Instructional videos for New York State Prescription Monitoring Program (PMP) users are available for several NYS PMP topics. These videos give on-line guidance in the use of various features and functions of the PMP. The trainings may also be accessed from within the PMP Help area. An HCS account is necessary for viewing.
- NYS Prescription Monitoring Program (PMP) Practitioner Reports: This video provides a demonstration for practitioners on how to use search tools to review practitioner history.
- NYS Prescription Monitoring Program (PMP) Assigning a Designee: This video provides a demonstration for practitioners on how to make designee assignments.
- NYS Prescription Monitoring Program (PMP) Reporting Suspicious Activity: This video provides a demonstration for practitioners on how to report suspicious activity.
- NYS Prescription Monitoring Program (PMP) Requirements for New to Practice Residents and Interns: This training reviews requirements and process for using the Prescription Monitoring Program (PMP) Registry for new to practice residents and interns in medical teaching facilities.
Prescription Monitoring Program (PMP)
An on-line instructional webinar is available which covers a variety of topics associated with the New York State Prescription Monitoring Program Registry (PMP) including the use of the PMP registry search and use of the PMP Data Collection Tool.
